Dr. Joan Mannick earned an A.B. in History from Harvard College and earned an M.D. from Harvard Medical School, where she finished her internship and residency at Brigham and Women's Hospital in Internal Medicine. She was the Medical Director at Genzyme and a faculty member at the University of Massachusetts Medical School and Harvard Medical School, after which she Dr. Mannick left to work at Novartis Institutes of Biomedical Research, where she became Executive Director, focusing on the fundamental pathways involved in aging. Dr. Mannick and Chen Schor co-founded resTORbio, a biopharmaceutical company that develops novel therapeutics in order to treat age-related diseases. Her company is creating interventions that target the mTORC1 pathway, the same pathway targeted by the commonly known compound rapamycin.